EU Legislative Reform: Pan-EU Launch Requirement Will ‘Take Two To Tango’
Companies are already used to uncertainty and will be able to adapt to the new product launch requirement in the EU’s legislative overhaul for the pharmaceutical sector, according to a commission representative.
You may also be interested in...
The EU’s regulatory reform package if unchanged could make orphan drug development less attractive, warn industry representatives.
The scheme still includes high rebate rates, but a controversial life cycle adjustment mechanism has been dropped.
The pharmaceutical legislation overhaul offers some solutions to the problem of immature applications.